Surgical failure risk factors

Article

There are several factors that might increase the risk of uncontrolled intraocular pressure (IOP) after phacoviscocanalostomy combination surgery, according to study results published in the September 2008 issue of Journal of Glaucoma.

There are several factors that might increase the risk of uncontrolled intraocular pressure (IOP) after phacoviscocanalostomy combination surgery, according to study results published in the September 2008 issue of Journal of Glaucoma. These factors include preoperative IOP levels, patient age, number of preoperative medications and postoperative IOP spikes.

Masami Park, MD, PhD of the Sensho-kai Eye Institute, Kyoto, Japan and colleagues used multivariate regression analysis to determine the impact of various factors on postoperative IOP in cataract and primary open angle glaucoma (POAG) patients (n=180) with a mean preoperative IOP of 20.2±3.8 mmHg. Five years after surgery, the mean IOP for all patients was 15.3±2.6 mmHg. The surgery was defined as successful if patients achieved an IOP reduction of ≥20%, or an overall IOP of ≤17 mmHg. Without the use of postoperative medications, 31.4% of surgeries were successful; with or without medication, 47.2% were successful.

High preoperative IOP and lower age were found to be negatively correlated to surgical success in the "with or without medications" group; higher preoperative IOP, a greater number of preoperative medications and postoperative IOP spikes (to levels of >30 mmHg) were associated with surgical failure in the "without medications" group; gender and complications (including ruptured Descemet's membrane, hyphaema and fibrin formation) did not have an impact on the surgical success rate of either group.

The team concluded that the risk of failure to control IOP after phacoviscocanalostomy was increased by preoperative IOP levels, lower patient age, a high number of preoperative medications and postoperative IOP spikes.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
© 2025 MJH Life Sciences

All rights reserved.